1. Despite strong Q2 FY2024 results and business expansion, Palantir is downgraded to 'Sell' due to mismatched valuation and projected EPS numbers. 2. Revenue and profitability have surged, but the stock's price is unjustified. 3. The stock is overvalued, trading higher than its 2021 peak with lower forward earnings.